医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Tongji Hospital Begins Installation of Mevion Proton Therapy System

2022年08月04日 PM08:00
このエントリーをはてなブックマークに追加


 

LITTLETON, Mass.

Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the accelerator for the MEVION S250i Proton Therapy System® was delivered on July 28, 2022, to Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology in Wuhan, China. This milestone commences the system installation at Tongji Hospital’s proton therapy center, the first of its kind in Central China.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220804005161/en/

Mevion begins system installation at Tongji Hospital in Wuhan, China (Photo: Business Wire)

Mevion begins system installation at Tongji Hospital in Wuhan, China (Photo: Business Wire)

The system at Tongji Hospital features Mevion’s industry leading HYPERSCAN® Pencil Beam Scanning (PBS) technology and Adaptive Aperture® pMLC. This powerful duo provides faster and more precise targeted dose delivery to tumors thus, minimizing the damage to surrounding healthy tissue and organs at risk. The system also integrates a diagnostic quality CT imaging system and a surface tracking system for high precision patient positioning and intra-fraction motion management.

Founded in 1900, Tongji Hospital currently treats over 6 million patients annually. It has developed into one of the world’s largest and most powerful oncology medical teaching and research facilities, and the recently opened Optics Valley Tongji Children’s Hospital is located on the same campus as the new proton therapy center. In addition to the Mevion system, the new proton therapy center will also be equipped with a cutting-edge whole-body PET/CT imaging system. Tongji Hospital has also built a second proton vault, making it China’s first proton center applying the One Plus One multi-system installation approach. This approach gives cancer centers the flexibility to add a second system in the future to correspond to the growth of patient volume and clinical expertise. By doing a staged installation approach, financial burdens are significantly reduced at the start of the clinical proton therapy program, and the risk of technology obsolescence is mitigated greatly.

“Mevion is excited to start the system installation at world-class Tongji Hospital, and we look forward to a continued partnership that will give patients in Central China much-needed access to proton therapy,” said Tina Yu, Ph.D., chief executive officer and president of Mevion. “We are proud of our technology that provides advanced cancer treatment to patients and allows hospitals to expand their proton therapy program at their own pace.”

*Mevion is actively seeking regulatory approval from the National Medical Products Administration (NMPA) in China.

About Mevion Medical Systems

Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion was the first company to innovate this new single-room platform and continues to further the science and application of proton therapy. Mevion’s flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the world’s smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com.

Follow us on Twitter: @MevionMedical

Connect with us on LinkedIn: Mevion Medical Systems

Like us on Facebook: MevionMedical

About Tongji Hospital

Tongji Hospital was founded in Shanghai in 1900 by German physician Erich Paulun and moved to Wuhan in 1955. After more than 120 years of construction and development, it has now become an innovative top-tier hospital in China. Tongji Hospital integrates clinical service, teaching, and scientific research with complete disciplines, prestigious doctors, outstanding faculty, great clinical expertise, state-of-the-art diagnostic and therapeutic equipment, strong research capabilities, and effective management. The Oncology Department of Tongji Hospital is one of the earliest oncology specialties established in China. After nearly 60 years of pioneering and innovation, it has developed into one of the largest and strongest oncology teaching and research institutions in Central China.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005161/en/

CONTACT

Jingyi Wang

Mevion Medical Systems

jwang@mevion.com

978-540-1499

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • European Commission Approves Celltrion Healthcare’s Vegzelma™ (CT-P16, biosimilar bevacizumab) for the Treatment of Multiple Types of Cancer
  • Aurion Biotech Nominated for Prix Galien Startup Award
  • ICS Cybersecurity Leader TXOne Networks Raises $70 Million in Series B Funding
  • Publication in Nature Molecular Psychiatry Supports Genuv’s Alternate Theory for Treatment of Alzheimer’s Disease
  • Restore EF試験で、Impella補助による高リスクPCI患者の心機能および症状改善を確認